Metalloproteinases and the modulation of GH signaling

Abstract

The metzincin metalloproteinase, tumor necrosis factor-α-converting enzyme (TACE), also known as ADAM (a disintegrin and metalloprotemase) 17, has recently been identified as an important enzyme for cleavage of the GH receptor (GHR) and shedding of GH-binding protein (GHBP). Proteolysis can be induced by phorbol esters, platelet-derived growth factor and serum; it is dependent on protein kinase C and partially on MAP kinase pathways. Proteolysis occurs at the cell surface, leading to extracellular release of GHBP and intracellular GHR remnant accumulation. The GHR remnant is further processed by γ-secretase activity, possibly leading to biologically active products. TACE-dependent GHR proteolysis can be inhibited by GH as the dimerized GHR is resistant to cleavage. The cleavage site lies within a short juxtamembranous stem region that extends between the transmembrane helix and the globular dimerization domain of the GHR. GHR proteolysis leads to down-regulation of functional GHRs at the cell surface, and has complex secondary effects on GH action via GHBP and GHR remnant generation.